If you are formula-feeding, tirzepatide can typically be restarted 24 weeks after delivery, once your provider clears you for non-essential medications
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Many patients remain on the 2.5 mg or 5 mg starting doses, which are primarily for tolerability rather than therapeutic effect, and do not reach the 10-15 mg weekly doses where maximal efficacy typically occurs
The cost can vary based on your personalized dosage and treatment plan